Colorectal cancer screening in HIV-infected patients 50 years of age and older: Missed opportunities for prevention

American Journal of Gastroenterology

Volumn 100, Issue 8, 2005, Pages 1805-1812

  Reinhold, Jean Pierre ^a   Moon, Marianne ^a   Tenner, Craig T ^a   Poles, Michael A ^a   Bini, Edmund J ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM ENEMA; CANCER PREVENTION; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RECORD; OCCULT BLOOD TEST; PRIORITY JOURNAL; REVIEW; SIGMOIDOSCOPY; AGED; ARTICLE; COLORECTAL TUMOR; FEMALE; MALE; MIDDLE AGED; OCCULT BLOOD;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; SIGMOIDOSCOPY;

EID: 25644434930     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.50038.x     Document Type: Review

References (43)

1. Palella FJ Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
2. Palella FJ Jr, Deloria-Knoll M, Chmiel JS, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med 2003;138:620-6.
3. Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001;135:17-26.
4. Porter K, Babiker A, Bhaskaran K, et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 2003;362:1267-74.
5. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet 2003;362:22-9.
6. Wood E, Low-Beer S, Bartholomew K, et al. Modern antiretroviral therapy improves life expectancy of gay and bisexual males in Vancouver's West End. Can J Public Health 2000;91:125-8.
7. Manfredi R. HIV disease and advanced age: An increasing therapeutic challenge. Drugs Aging 2002;19:647-69.
8. Lai D, Hardy RJ. An update on the impact of HIV/AIDS on life expectancy in the United States. AIDS 2004;18:1732-4.
9. Keiser O, Taffe P, Zwahlen M, et al. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS 2004;18:1835-43.
10. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
11. Pignone M, Rich M, Teutsch SM, et al. Screening for colorectal cancer in adults at average risk: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:132-41.
12. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 2004;54:41-52.
13. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003;124:544-60.
14. Rex DK, Johnson DA, Lieberman DA, et al. Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 2000;95:868-77.
15. American Society for Gastrointestinal Endoscopy. Guidelines for colorectal cancer screening and surveillance. Gastrointest Endosc 2000;51:777-82.
16. Pignone M, Saha S, Hoerger T, et al. Cost-effectiveness analyses of colorectal cancer screening: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:96-104.
17. Selby JV, Friedman GD, Quesenberry CP Jr., et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
18. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
19. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904-10.
20. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995;155:1741-8.
21. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
22. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
23. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
24. Nadel MR, Blackman DK, Shapiro JA, et al. Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Prev Med 2002;35:199-206.
25. Ko CW, Kreuter W, Baldwin LM. Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med 2002; 162:2581-6.
26. Centers for Disease Control and Prevention. Colorectal cancer test use among persons aged > or = 50 years-United States, 2001. MMWR Morb Mortal Wkly Rep 2003;52:193-6.
27. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 2003;98:2082-91.
28. Cokkinides VE, Chao A, Smith RA, et al. Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med 2003;36:85-91.
29. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004;100:2093-103.
30. Jha AK, Perlin JB, Kizer KW, et al. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med 2003;348:2218-27.
31. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998;351:1833-9.
32. Cooksley CD, Hwang LY, Waller DK, et al. HIV-related malignancies: Community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS 1999;10:795-802.
33. Fordyce EJ, Wang Z, Kahn AR, et al. Risk of cancer among women with AIDS in New York City. AIDS Public Policy J 2000;15:95-104.
34. Gallagher B, Wang Z, Schymura MJ, et al. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 2001;154:544-56.
35. Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001;285:1736-45.
36. Chiao EY, Krown SE. Update on non-acquired immunodeficiency syndrome-defining malignancies. Curr Opin Oncol 2003;15:389-97.
37. Cooley TP. Non-AIDS-defining cancer in HIV-infected people. Hematol Oncol Clin North Am 2003;17:889-99.
38. Bedimo R, Chen RY, Accortt NA, et al. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis 2004;39:1380-4.
39. Bonnet F, Lewden C, May T, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004;101:317-24.
40. Yeguez JF, Martinez SA, Sands DR, et al. Colorectal malignancies in HIV-positive patients. Am Surg 2003;69:981-7.
41. Cappell MS, Yao F, Cho KC. Colonic adenocarcinoma associated with the acquired immune deficiency syndrome. Cancer 1988;62:616-19.
42. Klugman AD, Schaffner J. Colon adenocarcinoma in HIV infection: A case report and review. Am J Gastroenterol 1994;89:254-6.
43. Demopoulos BP, Vamvakas E, Ehrlich JE, et al. Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Arch Pathol Lab Med 2003;127:589-92.